GlaxoSmithKline and Johnson & Johnson
Savvy businesses may look to make an international money transfer to put their funds into stocks like GlaxoSmithKline and Johnson & Johnson, after the FT Money Show branded them "very good value".
Brian Dennehy, managing director of Dennehy Weller & Co, explained that the company has been drawing up a "shopping list" of investment opportunities as the baby boomer generation looks to put their money into long-term projects.
"There are some fantastic global brands out there and individual stocks which are already looking [like] very good value," he explained.
"Things like GlaxoSmithKline in the UK, stocks like Johnson & Johnson - who famously do all the baby products in the US - a number of stocks like that are featuring heavily in funds such as M&G Global Dividend, or Artemis Global Income."
UK-based investors were warned that certain funds, such as Schroder Income, have a greater balance potential than many because they have a higher exposure to risky markets such as retail and property.
He added: "We mustn't overlook Asia. Asia performed extraordinarily well through 2008/2009 as a source of both growth and income - where the UK and much of the rest of the world suffered badly."
Foreign investors are currently looking for safe havens to put their money into, according to Interactive Investor.
The group reported that international instability has left negativity "ringing in the ears" of stock holders and businesses.
Uncertainty has pushed investors to seek "safety in numbers", which has led to an influx of interest in precious metals.